Skip to main content
. 2023 Jan 26;9:e41762. doi: 10.2196/41762

Figure 2.

Figure 2

Combined pain and indigestion medications in the Cancer Loyalty Card Study (CLOCS). Cases (n=153) were matched with controls with respect to age and store card use (HSR1 only, HSR2 only, or HSR1+HSR2) at a 2:1 ratio with replacement (n=306 controls in matched analysis, 77 unique individuals). Participants with a previous diagnosis of cancer were excluded. Where possible, the same 24 months of purchases from controls were aligned to each matched case leading to their diagnosis (–24 months to –1 month on the X-axis); otherwise, the last 24 months of purchases were used for controls. (A) Average cumulative purchases of combined pain and indigestion medications in cases (red) and controls (black). (B) Purchases summed on a sliding 3-month window for cases and controls comparing all purchases to purchase of both pain and indigestion medication bought together. The Fisher exact test was used to calculate the odds ratios and significance of enrichment at each month prior to diagnosis. Dx: diagnosis; HSR: high street retailer.